Showing 19,841 - 19,860 results of 20,193 for search '(( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 2 fold decrease ))', query time: 0.62s Refine Results
  1. 19841

    DataSheet1_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

    Published 2022
    “…The rats were intragastrically administered with 50% CCl<sub>4</sub> for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”
  2. 19842

    DataSheet2_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

    Published 2022
    “…The rats were intragastrically administered with 50% CCl<sub>4</sub> for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”
  3. 19843

    Data_Sheet_1_Unraveling shared susceptibility loci and Mendelian genetic associations linking educational attainment with multiple neuropsychiatric disorders.docx by Dongze Chen (12283640)

    Published 2024
    “…MR confirmed higher genetically predicted EA lower the risk of ADHD (OR<sub>IVW</sub>: 0.50; 95% CI: 0.39 to 0.63) and genetically predicted ADHD decreased the risk of EA (Causal effect: −2.8 months; 95% CI: −3.9 to −1.8).…”
  4. 19844

    Table_1_Genetic polymorphisms in CYP4F2 may be associated with lung cancer risk among females and no-smoking Chinese population.docx by Hongyang Shi (836187)

    Published 2023
    “…</p>Results<p>This study observed that rs12459936 was linked to an increased risk of LC in no-smoking participants (allele: OR = 1.38, p = 0.035; homozygote: OR = 2.00, p = 0.035; additive: OR = 1.40, p = 0.034) and females (allele: OR = 1.64, p = 0.002; homozygote: OR = 2.57, p = 0.006; heterozygous: OR = 2.56, p = 0.001; dominant: OR = 2.56, p < 0.002; additive: OR = 1.67, p = 0.002). Adversely, there was a significantly decreased LC risk for rs3093110 in no-smoking participants (heterozygous: OR = 0.56, p = 0.027; dominant: OR = 0.58, p = 0.035), rs3093193 (allele: OR = 0.66, p = 0.016; homozygote: OR = 0.33, p = 0.011; recessive: OR = 0.38, p = 0.021; additive: OR = 0.64, p = 0.014), rs3093144 (recessive: OR = 0.20, p = 0.045), and rs3093110 (allele: OR = 0.54, p = 0.010; heterozygous: OR = 0.50, p = 0.014; dominant: OR = 0.49, p = 0.010; additive: OR = 0.54, p = 0.011) in females.…”
  5. 19845

    Functional fitness in older women from southern brazil: normative scores and comparison with different countries by Gislaine Cristina Vagetti (5762195)

    Published 2021
    “…The non-parametric binomial test compared the 50th percentile value of Brazilian older women with those from other countries. …”
  6. 19846

    Image1_Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.TIF by Derrick Crawford (12414670)

    Published 2022
    “…Molar but not incisor tooth movement was inhibited over 50% by injection of the NO releasing nanoparticles. …”
  7. 19847

    Data_Sheet_1_Algal proliferation risk assessment using Vine Copula-based coupling methods in the South-to-North Water Diversion Project of China.PDF by Xizhi Nong (15310423)

    Published 2023
    “…The results showed that the WT gradually decreased from upstream to downstream, with a narrow range of 16.6–17.4°C, and the annual average concentrations of DO showed a gradual increase from upstream to downstream. …”
  8. 19848

    Data_Sheet_1_Exploring long COVID condition in Latin America: Its impact on patients’ activities and associated healthcare use.docx by Adriana Angarita-Fonseca (7253558)

    Published 2023
    “…Approximately 60% of respondents who experienced activity limitations sought a specialist and 50% consulted therapists.</p>Conclusions and relevance<p>Results supported previous findings in terms of the LCC demographics, and provided insight into LCC impact on patients’ activities and healthcare services used in LATAM. …”
  9. 19849

    <i>vt34</i> exhibits DA-dependent behaviors that parallel <i>dat-1</i> mutants. by Sarah B. Robinson (6693899)

    Published 2019
    “…<p>(A) <i>vt34</i> Swip is dependent on DOP-3 and CAT-2. …”
  10. 19850

    Stable RNA levels. by Zhongneng Xu (11177972)

    Published 2021
    “…The survival rate decreases at older RNA ages, i.e., the type B RNA survival rate is shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009188#pcbi.1009188.s003" target="_blank">S2 Table</a>. …”
  11. 19851

    Image2_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

    Published 2022
    “…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”
  12. 19852

    Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  13. 19853

    Image_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  14. 19854

    Image_1_Physical Responses of Pinctada fucata to Salinity Stress.TIF by Jingru Yang (2626306)

    Published 2022
    “…In this study, the salinity of 35‰ was used as the control, while the salinities of 20 and 50% salinity were used as the low and high salt treatment groups, respectively. …”
  15. 19855

    Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  16. 19856

    Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  17. 19857

    Deletion of <i>Foxm1</i> from macrophages induces activation of p38 MAPK pathway. by Chinmayee Goda (8694597)

    Published 2020
    “…<p><b>(A-B)</b> Interstitial and alveolar macrophages were isolated from bleomycin-treated my<i>Foxm1</i><sup>-/-</sup> and control lungs using FACS sorting. qRT-PCR shows decreased <i>Foxm1</i>, and <i>Dusp1</i> mRNAs and increased <i>Tnf</i>, <i>Ccl5</i>, <i>Il1β</i>, and <i>Il6</i> mRNAs in flow-sorted interstitial and alveolar macrophages from bleomycin-treated my<i>Foxm1</i><sup>-/-</sup> mice. …”
  18. 19858

    Supplementary file 1_Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.doc by Zhenghao Wu (9732511)

    Published 2025
    “…</p>Methods<p>In vivo experiments, bile duct ligation (BDL) induced PHT models were conducted in rats, followed by a 4-week FN treatment (50 mg/kg/day) administered via gavage. …”
  19. 19859

    Image1_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

    Published 2022
    “…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”
  20. 19860

    Data_Sheet_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.PDF by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”